Drugs.com - Pharma Industry News

AAD: Ivarmacitinib 4 mg, 8 mg Efficacious for Adults With Severe Alopecia Areata

THURSDAY, March 13, 2025 -- For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the...

Mar 13, 2025 - 19:07
 0
AAD: Ivarmacitinib 4 mg, 8 mg Efficacious for Adults With Severe Alopecia Areata
THURSDAY, March 13, 2025 -- For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the...
Read More

Tags:

Previous Article

COVID-19 Pandemic Linked to Developmental Changes in Kindergarteners

Next Article

Red Wine No Better Than White in Terms of Cancer Risk

Related Posts

Prenatal Alcohol Exposure Linked to Facial Development at Age 6 to 8 Years

Prenatal Alcohol Exposure Linked to Facial Development ...

Feb 13, 2025  0

Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer

Urine-Based Test Provides Accurate Testing Option for A...

Feb 11, 2025  0

Many Adults Have Suboptimal Five-Year Sleep Trajectories

Many Adults Have Suboptimal Five-Year Sleep Trajectories

Mar 6, 2025  0